摘要
目的探究脂蛋白磷脂酶A2在2型糖尿病大血管病变中的作用。方法选择26例2型糖尿病合并颈动脉粥样斑块患者和24例单纯2型糖尿病患者,分别测定脂蛋白磷脂酶A2水平,并对结果进行组间比较。结果 2型糖尿病合并颈动脉粥样斑块组脂蛋白磷脂酶A2水平高于单纯2型糖尿病患者,且低密度脂蛋白、糖化血红蛋白、颈动脉内中膜厚度水平均高于单纯2型糖尿病患者,组间比较差异存在统计学意义(P<0.05)。结论脂蛋白磷脂酶A2对2型糖尿病患者早期大血管病变有预测作用,为糖尿病大血管病变的早期干预提供了帮助。
Objective To investigate the relation between the level of lipoprotein-associated phospholipase A2 (Lp- PLA2) with type 2 diabetes mellitus and its vascular complications. Methods Collected the clinical data of 26 patients with type 2 diabetes mellitus complicated with carotid atherosclerotic plaque and 24 cases of type 2 diabetes mellitus without vascu- lopathy .The lipoprotein-associated phospholipase A2 levels were measured respectively, and carried on the comparison between two groups. Results The lipoprotein-associated phospholipase A2 level was significantly higher in patients with type 2 dia- betes mellitus complicated with carotid atherosclerotic plaque than that in patients with type 2 diabetes mellitus without macrovasculopathy. Meanwhile, the levels of low density lipoprotein cholesterol (HDL-c), glycosylated hemoglobin and carotid intima-media thickness in patients with type 2 diabetes mellitus complicated with carotid atherosclerotic plaque were also higher than that in patients with type 2 diabetes mellitus without macrovasculopathy. There was significant difference between two groups (P〈0.05). Conclusion The lipoprotein-associated phospholipase A2 has the predictional significance for early maerovasculopathy in type 2 diabetes mellitus, and is helpful for early intervene of diabetic macrovaseulopathy in type 2 diabetes mellitus.
出处
《中国现代医药杂志》
2015年第10期55-57,共3页
Modern Medicine Journal of China
关键词
脂蛋白磷脂酶A2
2型糖尿病
大血管病变
Lipoprotein-associated phospholipase A2(Lp-PLA2) Type 2 diabetes mellitus Maerovasculopathy